Home | Company | Services | Newsletter | Links | Contact Us | Job Oppotunities |

News

15.08.08

- Pfizer has teamed up with Cytos Biotechnology to develop, manufacture and commercialize vaccines for a defined number of human diseases.

- Underrepresenting viral codon-pairs representes a novel way to create live-attenuated viruses (nature 2008; 320: 1784-87)

 

Welcome to Buphycon Website!

Thank you for visiting our website. Please continue reading and learn more about us and how we can help you achieve your goals.

 

From competitive research, to product analysis, to market surveys, Buphycon consultancy provides clients with expert advice in the form they need to make informed decisions.

 

We provide scientific and regulatory affairs consultancy to individual investigators and the biopharmaceutical industry operating in the field of human and veterinary vaccinology. We also provide investors and business decision-makers with the information they need to make timely, informed investment and strategic decisions. Look at our Services for more information.

 

If you have any questions about our services, please feel free to contact us.

 

"Biopharmaceutic company, vaccine, adjuvant, scientific, regulatory affairs, consultancy, agency, bureau, investors, decision makers, microbes, viruses, parasites, bacteria, virologist, parasitologist, bacteriologist, vaccinologist, immunologist, diagnostics, experiment design, review, manuscript, report, protocols, process validation, dossier, submission, safety issues, training, regulatory strategy, investigators, researchers, animal, experiment, vaccinology, advisor network, FDA, EMEA, WHO, ICH, NIH, manufacturer, adverse event, GAVI, institute, Eudrapharm, VAERS, DG enterprise, industry, pharmacopoeia, IFPMA, newsletter, science, Fish, job, opportunities, risk assessment, registration, expert advice"

 

Qoute:

Knowledge of what is, does not open the door directly to what should be !!!!!!!!

 

Copyright © 2008 Buphycon Consultancy. All rights reserved